TELA Bio, Inc.

The momentum for this stock is not very good. TELA Bio, Inc. is not a good value stock. TELA Bio, Inc. is a mediocre stock to choose.
Log in to see more information.

News

Comparing TELA Bio (NASDAQ:TELA) and Spectral Medical (OTCMKTS:EDTXF)
Comparing TELA Bio (NASDAQ:TELA) and Spectral Medical (OTCMKTS:EDTXF)

Ticker Report Spectral Medical (OTCMKTS:EDTXF - Get Free Report) and TELA Bio (NASDAQ:TELA - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses...\n more…

Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Simply Wall St Unfortunately for some shareholders, the TELA Bio, Inc. ( NASDAQ:TELA ) share price has dived 33% in the last thirty...\n more…

Head-To-Head Comparison: TELA Bio (NASDAQ:TELA) versus Titan Medical (NASDAQ:TMDIF)
Head-To-Head Comparison: TELA Bio (NASDAQ:TELA) versus Titan Medical (NASDAQ:TMDIF)

Zolmax Titan Medical (NASDAQ:TMDIF - Get Free Report) and TELA Bio (NASDAQ:TELA - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…

TELA Bio (NASDAQ:TELA) Announces  Earnings Results, Misses Expectations By $0.06 EPS
TELA Bio (NASDAQ:TELA) Announces Earnings Results, Misses Expectations By $0.06 EPS

Ticker Report TELA Bio (NASDAQ:TELA - Get Free Report) posted its earnings results on Monday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.45...\n more…

TELA Bio (NASDAQ:TELA) Announces  Earnings Results, Misses Expectations By $0.06 EPS
TELA Bio (NASDAQ:TELA) Announces Earnings Results, Misses Expectations By $0.06 EPS

Zolmax TELA Bio (NASDAQ:TELA - Get Free Report) posted its earnings results on Monday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.45...\n more…

TELA Bio (NASDAQ:TELA) Given New $12.00 Price Target at Canaccord Genuity Group
TELA Bio (NASDAQ:TELA) Given New $12.00 Price Target at Canaccord Genuity Group

Ticker Report TELA Bio (NASDAQ:TELA - Free Report) had its price objective cut by Canaccord Genuity Group from $14.00 to $12.00 in a research note issued to investors on Tuesday, Benzinga reports. They currently...\n more…